The use of gabapentin was responsible for a significant improvement in pruritus (p=0.0020). Besides itching and hyperchromic stain on the back, patients reported paresthesia and back pain. It was observed that the main factor in the worsening of the rash is heat. For patients with post-burn pruritus, the dose of gabapentin was 5–10 mg/kg dose in pediatric patients and 300–900 mg/day in divided doses in adults [71,72]. Chronic pruritus is a distressing symptom that is often refractory to treatment. Patients frequently fail topical therapies and oral over-the-counter antihistamines, prompting the clinician to consider alternative therapies such as neuroactive agents. Herein, the use of gabapentin and pregabalin, 2 medications well known for treating neuropathic pain and epilepsy that are occasionally used for They are found to be promising alternative treatments for the relief of several forms of chronic pruritus, particularly uremic pruritus and neuropathic or neurogenic itch, in patients who fail conservative therapies. Keywords: gabapentin; itch; neurogenic itch; neuropathic itch; pregabalin; pruritus; uremic pruritus. Gabapentin is safe and found to be effective in uremic pruritus, cancer/hematologic causes, opiod-induced itch, brachioradial pruritis, burns pruritus, and pruritus of unknown origin. Further research is required in this area to establish whether gabapentin is consistently effective. Pruritus is the sensation of itching; it can be caused by dermatologic and systemic conditions. Gunal AI, Ozalp G, Yoldas TK, et al.; Gabapentin therapy for pruritus in haemodialysis patients Gabapentin and pregabalin are safe and efficacious options to treat older adults with chronic pruritus. Clinicians should consider prescribing pregabalin and gabapentin for pruritus, potentially replacing conventional treatments while refining dosing strategies and monitoring patient safety based on the reported outcomes. This systematic review examines the current literature on Gabapentin’s therapeutic effects on all forms of pruritus and compares its efficacy based on etiology, demographics, and dosages. Gabapentin or pregabalin relieved itching in 85% of 71 consecutively treated CKD patients. Patients should be advised about side effects and the drug initiated at a low dose. Patients intolerant of gabapentin may tolerate pregabalin. Gabapentin has been successfully used to treat cutaneous pain and pruritus in a variety of conditions. The authors describe a case of PHI successfully treated with a course of gabapentin and propose that this agent be considered for use in patients who present with PHI. “I usually start pregabalin after patients have failed gabapentin - at 50 to 70 mg pregabalin twice daily for a week or two, increasing to 150 to 300 mg twice daily as needed,” she says. Additionally, when patients who had been taking more than 600 to 1,200 mg daily of gabapentin or pregabalin discontinue treatment, “Always taper down. Gabapentin - small doses can be effective eg 100 mg OD to TDS, gradually increasing up to 300 mg TDS if needed. Gabapentin can be increased up to 600 mg three times a day over 3–4 weeks if there is no effect at a smaller dose. Consider Capsaicin ® cream 0.075% cream. Gabapentin should be considered as a treatment option in patients with suspected neuropathic scalp pruritus; the dose of gabapentin is usually started low and titrated up to an effective dose . Adverse effects reported include dizziness, peripheral edema, and worsening of diabetes mellitus. Although the mechanisms of pruritus and pain differ substantially in the acute phase, chronic pruritus and pain share similarities, particularly in their features of peripheral and central sensitivity enhancement, diminished inhibitory spinal cord control, as well as interactions between neural, immune, and glial elements. Gabapentin and pregabalin are safe and efficacious options to treat older adults with chronic pruritus. Prior to gabapentinoid initiation, the patient should be screened for: history of kidney disease; COPD or other lung disorders; current opioid medication use; history of falls, lightheadedness, or vertigo; history of mood disorders, including depression and suicidal ideation; history of The objectives of this study were to assess the efficacy of gabapentin in reducing pruritus scores of patients with uremic pruritus and evaluate its safety among dialysis patients. Meta-analysis of randomized controlled trials, using gabapentin as treatment for uremic pruritus among hemodialysis patients was included and analyzed using Review The use of gabapentin for neuropathic pain/pruritus is recommended only in patients over 18 years of age. The starting dose is 900mg/day (given as 300mg 3 times daily) and increased if necessary based on response. The novel antiepileptic drugs pregabalin and gabapentin demonstrated significant therapeutic value in the treatment of pruritus, with a favorable safety profile. Compared to commonly used pruritus treatments such as antihistamines and antidepressants, these medications offered a promising alternative. Based on this theory, researchers hypothesized that gabapentin may relieve itching by blocking pruritic stimulation at afferent nerves, and conducted a retrospective review of patients with cancer treated with IL-2 (n = 17). 53 The study showed that gabapentin treatment (300-3600 mg/d) was associated with significantly improved pruritus using
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |